Tag: healthcare

United Labs' renminbi-denominated convertible bond comes at attractive terms, but still falls below par.
By Anette Jönsson | 8 November 2011
China's second-biggest drug distributor prices its H-share offering below the mid-point, but at a modest 2.4% discount versus its A-shares.
By Anette Jönsson | 16 May 2011
Shanghai Pharma's IPO beats the odds to find good demand in difficult market conditions.
By Lillian Liu | 4 May 2011
The Chinese manufacturer of cardio-cerebral vascular drugs raises $741 million by pricing its shares at 26.7 times next year's earnings, making it the most expensive new stock ...
By Lillian Liu | 22 October 2010
If successful, this will be the second Chinese medical company in the past month to transfer listings from another stock exchange to Hong Kong.
By Lillian Liu | 13 October 2010
M&A
The Indian hospital operator agrees to sell its shares in Parkway to IHH and abandons its own bid for the Singapore-listed healthcare provider after the Khazanah subsidiary ...
By Anette Jönsson | 27 July 2010
M&A
The Indian hospital operator offers to pay S$3.80 per Parkway share for the three-quarters of the firm it doesn't already own, beating Khazanah's bid of S$3.78 for a smaller ...
By Anette Jönsson | 2 July 2010
The Malaysian operator of nursing schools prices at the top and upsizes in full for a total deal size of $243 million.
By Anette Jönsson | 6 May 2010
The operator of cancer treatment centres avoids the fate of two other Chinese listing candidates which were forced to re-price or pull their US IPOs, but the stock still slumps ...
By Anette Jönsson | 14 December 2009
Concord Medical Services aims to raise up to $138 million from an IPO and is expected to start trading on the NYSE late next week.
By Anette Jönsson | 3 December 2009
The Chinese pharmaceutical distributor prices at the top to raise $1.13 billion after attracting $110 billion worth of orders. Separately, Digital China raises $49 million from ...
By Anette Jönsson | 17 September 2009
The Chinese distributor of pharmaceutical products will be the first company to take orders for a Hong Kong listing after the summer and has set the price range at HK12.25 to ...
By Anette Jönsson | 4 September 2009
Patching up the Chinese healthcare system could have ramifications across the entire economy.
By Daniel Inman | 19 June 2009
China's developing healthcare system has the potential to boost a number of sectors including insurance, pharmaceuticals and medical equipment manufacturing.
By Daniel Inman | 24 November 2008
The co-head of Citi’s global retail group will lead the bank’s consumer and healthcare group in Asia.
By Yi Tin Chak | 25 February 2008
Wockhardt Hospitals and Emaar MGF Land lower their indicative price bands on the eve of opening the bookbuilding.
By Anette Jönsson | 1 February 2008
The insurance and healthcare provider prices the fully marketed deal just below the mid-point of the range.
By Anette Jönsson | 12 June 2007
Support from long-term investors who are keen on the sector allows Fortis Healthcare to price its offering close to the top of the range.
By Anette Jönsson | 24 April 2007
More than 500 investors want a piece of Mainland industry leader Mindray, allowing it to raise $270 million via Goldman Sachs and UBS.
By Anette Jönsson | 27 September 2006
Bangkok Dusit Medical applies unusual structure to avoid dollar exposure; investor returns will depend on baht exchange rate.
By Anette Jönsson | 10 July 2006
1 2 | Next »
Polls
With Valentine's Day approaching, who would make the best match for Olympus?




   |   View results
Nikon
  23%
 
Sony
  18%
 
Panasonic
  18%
 
Fujifilm
  25%
 
Samsung
  18%
TOTAL VOTES: 57

 
Magazine
FinanceAsia Magazine
FinanceAsia
December 2011/January 2012